Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Other Operating Expenses (2022 - 2026)

Cannabis Bioscience International Holdings' Other Operating Expenses history spans 5 years, with the latest figure at $62139.0 for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 1.68% to $62139.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $414264.0, a 7.44% increase, with the full-year FY2025 number at $516557.0, up 8.33% from a year prior.
  • Other Operating Expenses hit $62139.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from $96270.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for CBIH hit a ceiling of $241961.0 in Q1 2023 and a floor of $56261.0 in Q3 2025.
  • Historically, Other Operating Expenses has averaged $134840.0 across 5 years, with a median of $122386.0 in 2023.
  • The widest YoY moves for Other Operating Expenses: up 190.92% in 2025, down 70.14% in 2025.
  • Tracing CBIH's Other Operating Expenses over 5 years: stood at $218680.0 in 2022, then tumbled by 52.74% to $103354.0 in 2023, then plummeted by 34.78% to $67408.0 in 2024, then skyrocketed by 42.82% to $96270.0 in 2025, then plummeted by 35.45% to $62139.0 in 2026.
  • Business Quant data shows Other Operating Expenses for CBIH at $62139.0 in Q1 2026, $96270.0 in Q4 2025, and $56261.0 in Q3 2025.